Global pharma major Lupin Limited announced the launch of raltegravir tablets USP, 600 mg in the United States following the approval from the US FDA for its Abbreviated New Drug Application.

Explore five Android tablets with pen support, comparing displays, processors, bundled accessories and battery life across ...

Huawei OSTA trademark details have surfaced online, suggesting that the new sub-brand won’t be limited to smartphones but ...

TCL has launched a new range of affordable and mid-range smartphones and tablets featuring its new proprietary paper-like ...

Galaxy Tab S12 or iPad? We compare S Pen vs Apple Pencil, colour accuracy, storage, and apps to find the best creative tablet ...

A new survey found some teenagers believe being without phones, tablets and other electronic devices would leave them feeling ...

There's no need to wait around for Black Friday if you're in the market for a tablet. These deals are live right now and ...

The husband, who cannot be named, has already admitted drugging his wife to rape and sexually abuse her over more than two ...

Mexico restricted the use of mobile phones and tablets in public and private primary and secondary schools from November 3.

Alan Keelan, Jonathan Kirk and Jordan Wallace deny the charges against them A husband who for years raped his wife while she was unconscious complained that tablets he was sent for drugging her tasted ...

Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Raltegravir Tablets USP, 600 mg in the United States ...